Nyxoah NYXH Stock
9.01 USD
{{ price }}
-7.304527%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Medical Instruments & Supplies
COUNTRY
United States
Exchange
NasdaqGM
Market Cap
276.66M USD
LOW - HIGH [24H]
8.6
-
10.25 USD
VOLUME [24H]
35.56K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.66 USD
Nyxoah Price Chart
Nyxoah NYXH Financial and Trading Overview
| Nyxoah stock price | 9.01 USD |
| Previous Close | 7.81 USD |
| Open | 8.06 USD |
| Bid | 0 USD x 1100 |
| Ask | 0 USD x 2200 |
| Day's Range | 7.65 - 8.22 USD |
| 52 Week Range | 4.36 - 11.32 USD |
| Volume | 967 USD |
| Avg. Volume | 32.33K USD |
| Market Cap | 229.3M USD |
| Beta (5Y Monthly) | 0.602434 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.66 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 12.86 USD |
NYXH Valuation Measures
| Enterprise Value | 142.82M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.6783624 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 80.03351 |
| Price/Book (mrq) | 1.8099548 |
| Enterprise Value/Revenue | 49.851 |
| Enterprise Value/EBITDA | -3.951 |
Trading Information
Nyxoah Stock Price History
| Beta (5Y Monthly) | 0.602434 |
| 52-Week Change | -29.015% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 11.32 USD |
| 52 Week Low | 4.36 USD |
| 50-Day Moving Average | 8.18 USD |
| 200-Day Moving Average | 6.48 USD |
NYXH Share Statistics
| Avg. Volume (3 month) | 32.33K USD |
| Avg. Daily Volume (10-Days) | 7.97K USD |
| Shares Outstanding | 28.66M |
| Float | 11.79M |
| Short Ratio | 8.23 |
| % Held by Insiders | 50.13% |
| % Held by Institutions | 29.69% |
| Shares Short | 178.39K |
| Short % of Float | 1.01% |
| Short % of Shares Outstanding | 0.61% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1277.97% |
| Gross Margin | 63.83% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -14.44% |
| Return on Equity (ttm) | -27.22% |
Income Statement
| Revenue (ttm) | 2.87M USD |
| Revenue Per Share (ttm) | 0.11 USD |
| Quarterly Revenue Growth (yoy) | -33.20% |
| Gross Profit (ttm) | 1.93M USD |
| EBITDA | -36147000 USD |
| Net Income Avi to Common (ttm) | -36435000 USD |
| Diluted EPS (ttm) | -1.53 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 96.07M USD |
| Total Cash Per Share (mrq) | 3.4 USD |
| Total Debt (mrq) | 12.59M USD |
| Total Debt/Equity (mrq) | 10.07 USD |
| Current Ratio (mrq) | 7.108 |
| Book Value Per Share (mrq) | 4.42 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -33933000 USD |
| Levered Free Cash Flow (ttm) | -32395376 USD |
Profile of Nyxoah
| Country | United States |
| State | N/A |
| City | Mont-Saint-Guibert |
| Address | Rue Edouard Belin 12 |
| ZIP | 1435 |
| Phone | 32 10 22 23 55 |
| Website | https://www.nyxoah.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 137 |
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Q&A For Nyxoah Stock
What is a current NYXH stock price?
Nyxoah NYXH stock price today per share is 9.01 USD.
How to purchase Nyxoah stock?
You can buy NYXH shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nyxoah?
The stock symbol or ticker of Nyxoah is NYXH.
Which industry does the Nyxoah company belong to?
The Nyxoah industry is Medical Instruments & Supplies.
How many shares does Nyxoah have in circulation?
The max supply of Nyxoah shares is 30.71M.
What is Nyxoah Price to Earnings Ratio (PE Ratio)?
Nyxoah PE Ratio is now.
What was Nyxoah earnings per share over the trailing 12 months (TTM)?
Nyxoah EPS is -1.66 USD over the trailing 12 months.
Which sector does the Nyxoah company belong to?
The Nyxoah sector is Healthcare.
Nyxoah NYXH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}